Answer
Jun 23, 2026 - 10:40 AM
The main downsides of Omnipod are related to the potential risks and practical challenges of using a tubeless insulin pump.
1. Risk of insulin under-delivery or over-delivery
Like any insulin pump, a Pod malfunction, blockage, software issue, or communication failure can interrupt insulin delivery. Hardware defects, software glitches, and Pod failures can lead to hypoglycemia (low blood sugar), hyperglycemia (high blood sugar), or diabetic ketoacidosis (DKA).
2. You still have to monitor glucose carefully
Omnipod 5 relies on accurate continuous glucose monitor (CGM) readings in automated mode. If the sensor provides inaccurate glucose readings, the system may deliver too much or too little insulin, potentially causing hypoglycemia or hyperglycemia.
3. Skin irritation, adhesive reactions, and site infections
The Pod attaches directly to the skin for up to 72 hours. Some users experience redness, itching, irritation, bleeding, discomfort, or infection at the application site. Regularly rotating application sites can help reduce these problems.
4. Pod bulk and placement issues
Although Omnipod is tubeless, the Pod is still a noticeable device attached to the body. It may become uncomfortable during sleep, exercise, or certain activities. Clothing, sweating, physical contact, and adhesive problems can also cause the Pod to become dislodged.
5. Frequent Pod replacements
Pods generally need to be replaced every 72 hours (3 days), although some users may need to change them every 48 hours depending on their insulin requirements. Frequent replacements mean managing ongoing supplies, prescription refills, travel backups, and medical waste.
6. Cost and insurance coverage
Omnipod requires a prescription, and the cost can vary significantly depending on insurance coverage, pharmacy pricing, and the number of Pods needed. Out-of-pocket expenses may be a concern for people without adequate insurance coverage.
7. Device and smartphone compatibility limitations
Omnipod 5 works with specific compatible smartphones, controllers, and CGM systems. Not all devices are supported, and using unauthorized or incompatible devices may interfere with insulin delivery or automated glucose management.
8. Alarms and troubleshooting
Users must respond to system alerts, monitor device performance, maintain adequate supplies, and understand how to manage Pod failures. Keeping backup insulin delivery supplies available is essential in case the system stops working.
9. Not suitable for everyone
Omnipod 5 may not be appropriate for individuals who cannot monitor their glucose levels as instructed, respond to alerts, operate the device correctly, or maintain regular contact with their healthcare provider. The safety of its automated insulin delivery algorithm has also not been established for certain populations, including individuals requiring less than 5 units of insulin daily.
10. Product recalls and manufacturing issues
In March 2026, Insulet reported a correction involving specific Omnipod 5 Pod lots because of a potential defect in internal tubing. This issue could allow insulin to leak inside the Pod, resulting in inadequate insulin delivery and potentially causing high blood glucose or diabetic ketoacidosis. Users with affected Pods should check their lot numbers and follow the manufacturer's replacement instructions.
The most important medical concern is that Omnipod delivers rapid-acting insulin without a separate supply of long-acting insulin. If insulin delivery is interrupted, blood glucose levels can rise quickly, increasing the risk of diabetic ketoacidosis.
Seek immediate medical attention if you experience high blood glucose with moderate or large ketones, persistent vomiting, rapid or deep breathing, severe weakness, confusion, or other symptoms of diabetic ketoacidosis.
